Table: Fuji Pharmaceutical -2020/21 group results

Fuji Pharma

05/11/2021 08:00

Nov 5 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2021    Sep 30, 2020   Sep 30, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           33.99           33.79          35.97        17.47    
               (+0.6 pct)      (-6.9 pct)     (+10.2 pct)   (+5.8 pct) 
  Operating        3.35            3.14           3.49         1.64    
               (+6.7 pct)      (-24.8 pct)    (+4.2 pct)   (-38.8 pct) 
  Recurring        3.25            2.98           3.54         1.67    
               (+9.0 pct)      (-28.4 pct)    (+8.9 pct)   (-39.1 pct) 
  Net
  Net              2.43            2.09           2.56         1.21    
               (+16.6 pct)     (-29.6 pct)    (+5.3 pct)   (-40.1 pct) 
  EPS           90.54 yen       66.94 yen     105.49 yen    49.86 yen  
  Ann Div       29.00 yen       29.00 yen      32.00 yen               
  -Q2 Div       14.00 yen       14.00 yen      15.00 yen               
  -Q4 Div       15.00 yen       15.00 yen      17.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T